Horizon Therapeutics plc CEO Net Worth

Last Updated Mar 10, 2025
CEO NameTimothy P. Walbert
NationalityUnited States
Net Worth Estimation$150 million

Timothy P. Walbert's estimated net worth of around $150 million is primarily attributed to his executive compensation, equity holdings, and stock sales from his long tenure as CEO and Chairman of Horizon Therapeutics plc. His financial gains are further supported by the company's growth, acquisitions, and its pending $27.8 billion acquisition by Amgen.

Timothy P. Walbert's estimated net worth is $150,000,000, which is 67% higher than the maximum range ($90,000,000) for CEOs in the healthcare sector. His net worth also surpasses the minimum estimate of $10,000,000 by 15 times.

Business Category: Healthcare

Minimum Net Worth (estimation): 10000000 USD
Maximum Net Worth (estimation): 90000000 USD


Timothy P. Walbert Performance in Horizon Therapeutics plc

Timothy P. Walbert, CEO of Horizon Therapeutics plc, demonstrates strategic leadership with a strong focus on innovative decision-making that drives patient-centric solutions and sustainable growth. His performance is marked by successful portfolio expansion, robust financial results, and enhanced shareholder value through targeted acquisitions and efficient operations. Under Walbert's leadership, Horizon has significantly strengthened its market position in rare disease therapeutics, elevating the company to a global biopharmaceutical leader.


Latest News

Horizon Therapeutics CEO Tim Walbert Honored with RARE Champion Award

Tim Walbert, chairman, president, and CEO of Horizon Therapeutics plc, received the 2020 RARE Champion of Hope Industry Partner award from Global Genes for his leadership and advocacy in the rare disease community, citing both his personal experience and company's commitment to advancing therapies and support for patients with rare diseases. Horizon under Walbert has emphasized science, compassion, and collaboration to impact underserved communities.
Source: http://www.businesswire.com/news/home/20201113005107/en/Horizon-Therapeutics-plc-CEO-Tim-Walbert-Honored-with-RARE-Champion-Award-at-Global-Genes-Champions-of-Hope-Gala



Disclaimer.
The information provided in this document is for general informational purposes only and is not guaranteed to be complete. While we strive to ensure the accuracy of the content, we cannot guarantee that the details mentioned are up-to-date or applicable to all scenarios. Topics about Horizon Therapeutics plc are subject to change from time to time.

Comments

No comment yet